Clonidine (Corium International, Inc.)
Welcome to the PulseAid listing for the Clonidine drug offered from Corium International, Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Corium International, Inc. |
NON-PROPRIETARY NAME: | CLONIDINE |
SUBSTANCE NAME: | CLONIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-08-03 |
END MARKETING DATE: | 0000-00-00 |
Clonidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Clonidine from Corium International, Inc. |
LABELER NAME: | Corium International, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.1(mg/24h) |
START MARKETING DATE: | 2016-08-03 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65038-040_44a7e257-1fe2-42bb-e054-00144ff8d46c |
PRODUCT NDC: | 65038-040 |
APPLICATION NUMBER: | ANDA079090 |
Other CLONIDINE Pharmaceutical Manufacturers / Labelers: